PrEP refers to a daily dose of the HIV medication Truvada that can be used by those who are HIV-negative to reduce greatly their risk of becoming infected. The risk reduction percentages vary depending on how closely the individual adheres to the daily drug regimen, but overall, research studies indicate if PrEP is taken correctly, it reduces HIV transmission risk by 96%-99%.

In keeping with current recommendation by both the Centers for Disease Control (CDC) and the World Health Organization (WHO) (see below for more details), Housing Works supports the expanded use of PrEP as an additional HIV prevention tool, ideally in combination with condoms, but certainly for individuals who are at high risk of contracting HIV.